Brazil Anvisa includes 2,4-D and glyphosate for Residue Analysis Program

The inclusion of the 2,4-D herbicides and glyphosate in the list of substances researched is one of the new developments in this year’s edition of the “Program of Agrochemicals Residue on Food.”

 

Responsible for the study, the Brazilian National Health Surveillance Agency (Anvisa), along with the Health Surveillance of states and municipalities, have already started collecting samples.

 

According to Anvisa, the program passed through a restructuring last year and the collection in 2017 will be created under a new format. Other news is that the number of products monitored jumped from 25 to 36, representing 80 per cent of product consumption for the vegetable original from the Brazilian population, according to data from the Brazilian Institute of Geography and Statistics (IBGE).

 

“The foods will be monitored during the next three years within a multi-annual plan. The samples’ quantity monitored will be increased with proportional consumption numbers of each food per state unit. This increase has enabled the expansion of the quantity of collection of municipalities that jumped from 30 to over 70 locations,” announced Anvisa.

 

According to the agency, since August 28, collections were made in the supermarkets of several municipalities in five regions of the country. These crops will be monitored during the first period of 32 weeks of the multi-annual plan: pineapple, lettuce, rice, sweet potato, beet, carrot, guava, orange, mango, chili, tomato, and grape.

 

“This is a result of an action between Anvisa, local health surveillance and public health laboratories. The goal of the program is to monitor residues of agrochemicals in foods that reach the table of consumers, aiming to reduce eventual health risk. The results subsidize measures that would be adopted regarding the irregularities found and enable the evaluation and mapping of the situation in which the residue of agrochemical in foods can represent a risk for the Brazilian population,” concluded Anvisa.